Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies.

Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies.

Item
http://www.wikidata.org/entity/Q38599969
Systematic review and meta-analysis of imipenem-resistant Pseudomonas aeruginosa prevalence in Iran.Characterization of Pseudomonas aeruginosa phage K5 genome and identification of its receptor related genes.Unravelling the Genome-Wide Contributions of Specific 2-Alkyl-4-Quinolones and PqsE to Quorum Sensing in Pseudomonas aeruginosaCharacterization of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione resistance in pyomelanogenic Pseudomonas aeruginosa DKN343.Sensitivity to Antimicrobial Drugs of Pseudomonas Aeruginosa Extreme-Resistant Strains Isolated in the Major Hospitals of Central Kazakhstan.Knowledge, awareness, and attitudes toward antibiotic use and antimicrobial resistance among Saudi population.Efficacy comparison of adjuvants in PcrV vaccine against Pseudomonas aeruginosa pneumonia.Establishing Genotype-to-Phenotype Relationships in Bacteria Causing Hospital-Acquired Pneumonia: A Prelude to the Application of Clinical Metagenomics.Antibiotics potentiating potential of catharanthine against superbug Pseudomonas aeruginosa.How to manage Pseudomonas aeruginosa infections.Molecular Typing and Carbapenem Resistance Mechanisms of Pseudomonas aeruginosa Isolated From a Chinese Burn Center From 2011 to 2016.Risk factors for mortality in patients with acute leukemia and bloodstream infections in the era of multiresistance.Pseudomonas aeruginosa Isolates from Spanish Children: Occurrence in Faecal Samples, Antimicrobial Resistance, Virulence, and Molecular Typing.Higher Prevalence of PldA, a -Kingdom H2-Type VI Secretion System Effector, in Clinical Isolates Responsible for Acute Infections and in Multidrug Resistant Strains
P2860

Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies.

Item
http://www.wikidata.org/entity/Q38599969
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Pseudomonas aeruginosa: arsena ...... uture antimicrobial therapies.
@en
type
label
Pseudomonas aeruginosa: arsena ...... uture antimicrobial therapies.
@en
prefLabel
Pseudomonas aeruginosa: arsena ...... uture antimicrobial therapies.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Pseudomonas aeruginosa: arsena ...... uture antimicrobial therapies.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698